Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Fully Resorbable Sinus Drug-eluting Stents in Patients With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps After Surgery: A Prospective, Randomized Controlled Trial

NCT07498374 is registered in ClinicalTrials.gov with Tang-Du Hospital as lead sponsor.

NCT NCT07498374
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07498374 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Fully Resorbable Sinus Drug-eluting Stents in Patients With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps After Surgery: A Prospective, Randomized Controlled Trial
Lead sponsor
Tang-Du Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
January 21, 2026
Completion date
December 31, 2028
Enrollment
192 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

eosinophilic chronic rhinosinusitis with nasal polyps